These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 29738771
1. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway. Ishibashi O, Akagi I, Ogawa Y, Inui T. Biochem Biophys Res Commun; 2018 Jun 22; 501(2):507-513. PubMed ID: 29738771 [Abstract] [Full Text] [Related]
2. Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma. He X, Zhang Z, Li M, Li S, Ren L, Zhu H, Xiao B, Shi R. BMC Cancer; 2015 Aug 06; 15():575. PubMed ID: 26245343 [Abstract] [Full Text] [Related]
3. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R. BMC Cancer; 2015 Jan 31; 15():29. PubMed ID: 25637514 [Abstract] [Full Text] [Related]
4. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells. Li X, Chen D, Li M, Gao X, Shi G, Zhao H. Chem Biol Interact; 2018 May 25; 288():76-82. PubMed ID: 29680210 [Abstract] [Full Text] [Related]
5. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway. Guanen Q, Junjie S, Baolin W, Chaoyang W, Yajuan Y, Jing L, Junpeng L, Gaili N, Zhongping W, Jun W. Biomed Pharmacother; 2018 Sep 25; 105():350-361. PubMed ID: 29864623 [Abstract] [Full Text] [Related]
6. MicroRNA-488-3p inhibits proliferation and induces apoptosis by targeting ZBTB2 in esophageal squamous cell carcinoma. Yang Y, Li H, He Z, Xie D, Ni J, Lin X. J Cell Biochem; 2019 Nov 25; 120(11):18702-18713. PubMed ID: 31243806 [Abstract] [Full Text] [Related]
7. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway. Nie ZC, Weng WH, Shang YS, Long Y, Li J, Xu YT, Li Z. Int J Clin Exp Pathol; 2015 Nov 25; 8(5):4745-54. PubMed ID: 26191164 [Abstract] [Full Text] [Related]
8. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling. Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, Huang E, Xiong S, Xu F, Liu G, Ge D, Chu Y. Clin Cancer Res; 2015 Feb 15; 21(4):854-63. PubMed ID: 25512445 [Abstract] [Full Text] [Related]
9. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R, Chu X, Chen L, Song H. J Exp Clin Cancer Res; 2017 Nov 16; 36(1):161. PubMed ID: 29145896 [Abstract] [Full Text] [Related]
10. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway. He Y, Mingyan E, Wang C, Liu G, Shi M, Liu S. Int J Biol Macromol; 2019 Mar 15; 125():116-123. PubMed ID: 30508543 [Abstract] [Full Text] [Related]
11. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN. Jin YY, Chen QJ, Xu K, Ren HT, Bao X, Ma YN, Wei Y, Ma HB. Mol Cell Biochem; 2016 Nov 15; 422(1-2):161-170. PubMed ID: 27644195 [Abstract] [Full Text] [Related]
12. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT. Wang F, Wang J, Yang X, Chen D, Wang L. Diagn Pathol; 2016 Sep 15; 11(1):88. PubMed ID: 27628042 [Abstract] [Full Text] [Related]
13. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer. Zhao L, Li R, Xu S, Li Y, Zhao P, Dong W, Liu Z, Zhao Q, Tan B. Acta Biochim Biophys Sin (Shanghai); 2018 Feb 01; 50(2):171-180. PubMed ID: 29329360 [Abstract] [Full Text] [Related]
14. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. Zhang HF, Alshareef A, Wu C, Li S, Jiao JW, Cao HH, Lai R, Xu LY, Li EM. Oncotarget; 2015 Oct 06; 6(30):28949-60. PubMed ID: 26334393 [Abstract] [Full Text] [Related]
15. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway. Qi B, Wang Y, Chen ZJ, Li XN, Qi Y, Yang Y, Cui GH, Guo HZ, Li WH, Zhao S. World J Gastroenterol; 2017 Dec 07; 23(45):7965-7977. PubMed ID: 29259372 [Abstract] [Full Text] [Related]
16. miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma. Lin C, Liu A, Zhu J, Zhang X, Wu G, Ren P, Wu J, Li M, Li J, Song L. Nat Commun; 2014 Aug 06; 5():4620. PubMed ID: 25099196 [Abstract] [Full Text] [Related]
17. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway. Liang W, Wang C, Wang J, Zhang M. Appl Biochem Biotechnol; 2022 Sep 06; 194(9):1-16. PubMed ID: 35522362 [Abstract] [Full Text] [Related]
18. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. Int J Cancer; 2010 Dec 15; 127(12):2804-14. PubMed ID: 21351259 [Abstract] [Full Text] [Related]
19. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma. He Z, Yi J, Liu X, Chen J, Han S, Jin L, Chen L, Song H. Mol Cancer; 2016 Jun 29; 15(1):51. PubMed ID: 27358073 [Abstract] [Full Text] [Related]
20. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET. Wang P, Yang Z, Ye T, Shao F, Li J, Sun N, He J. J Exp Clin Cancer Res; 2020 Jan 09; 39(1):7. PubMed ID: 31918742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]